Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Apipharma

US Class II Ongoing · initiated 2025-04-09

CGMP Deviations

Cardinal Health Inc.

US Class II Ongoing · initiated 2025-04-09

Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a…

Teva 5-ASA tablet (aka MESALAMINE)

Canada Type II Ongoing · initiated 2025-04-07

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-04-03

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-04-02

Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-04-02

Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-04-02

Lack of assurance of sterility. Bacterial contamination detected in some media fill units

B. Braun Medical Inc

US Class II Ongoing · initiated 2025-03-31

Presence of Particulate Matter

Denver Solutions, LLC DBA Leiters Health

US Class II Ongoing · initiated 2025-03-31

Lack of Assurance of Sterility: Leaking/damaged syringes.

Medisca Inc.

US Class II Terminated · initiated 2025-03-31

CGMP Deviations

Denver Solutions, LLC DBA Leiters Health

US Class II Ongoing · initiated 2025-03-31

Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health

US Class II Ongoing · initiated 2025-03-31

Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health

US Class II Ongoing · initiated 2025-03-31

Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health

US Class II Ongoing · initiated 2025-03-31

Lack of Assurance of Sterility: Leaking/damaged syringes.

Sambucus Organic Cold & Flu syrup

Canada Type II Ongoing · initiated 2025-03-31

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Neupogen 300 mcg/mL (480 mcg /1.6 mL) vials

Canada Type III Ongoing · initiated 2025-03-27

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Breckenridge Pharmaceutical, Inc.

US Class II Ongoing · initiated 2025-03-26

CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.

Chattem Inc

US Class II Ongoing · initiated 2025-03-26

CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Inta…

Mint-Rosuvastatin Tablet

Canada Type III Ongoing · initiated 2025-03-26

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Amplify - Peach Mango powder

Canada Type II Ongoing · initiated 2025-03-26

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Believe Supplements products

Canada Type II Ongoing · initiated 2025-03-26

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Amerisource Health Services LLC

US Class II Terminated · initiated 2025-03-24

cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.

RemedyRepack Inc.

US Class II Ongoing · initiated 2025-03-24

CGMP Deviations

Somerset Therapeutics Private Limited

US Class II Ongoing · initiated 2025-03-21

Lack of Assurance of Sterility: Media fill with bacterial contamination

Zydus Pharmaceuticals (USA) Inc

US Class II Completed · initiated 2025-03-21

Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.